Stock Analysis
Industry Analysts Just Upgraded Their ageas SA/NV (EBR:AGS) Revenue Forecasts By 78%
Celebrations may be in order for ageas SA/NV (EBR:AGS) shareholders, with the analysts delivering a significant upgrade to their statutory estimates for the company. The analysts have sharply increased their revenue numbers, with a view that ageas will make substantially more sales than they'd previously expected.
Following the upgrade, the latest consensus from ageas' nine analysts is for revenues of €13b in 2024, which would reflect a major 58% improvement in sales compared to the last 12 months. Per-share earnings are expected to swell 18% to €6.86. Previously, the analysts had been modelling revenues of €7.2b and earnings per share (EPS) of €6.80 in 2024. There's clearly been a surge in bullishness around the company's sales pipeline, even if there's no real change in earnings per share forecasts.
View our latest analysis for ageas
Even though revenue forecasts increased, there was no change to the consensus price target of €50.74, suggesting the analysts are focused on earnings as the driver of value creation.
These estimates are interesting, but it can be useful to paint some more broad strokes when seeing how forecasts compare, both to the ageas' past performance and to peers in the same industry. One thing stands out from these estimates, which is that ageas is forecast to grow faster in the future than it has in the past, with revenues expected to display 150% annualised growth until the end of 2024. If achieved, this would be a much better result than the 14% annual decline over the past five years. Compare this against analyst estimates for the broader industry, which suggest that (in aggregate) industry revenues are expected to grow 5.0% annually. Not only are ageas' revenues expected to improve, it seems that the analysts are also expecting it to grow faster than the wider industry.
The Bottom Line
The most important thing to take away is that there's been no major change in sentiment, with analysts reconfirming that earnings per share are expected to continue performing in line with their prior expectations. Fortunately, analysts also upgraded their revenue estimates, and our data indicates sales are expected to perform better than the wider market. Seeing the dramatic upgrade to this year's forecasts, it might be time to take another look at ageas.
Still, the long-term prospects of the business are much more relevant than next year's earnings. At Simply Wall St, we have a full range of analyst estimates for ageas going out to 2026, and you can see them free on our platform here..
Of course, seeing company management invest large sums of money in a stock can be just as useful as knowing whether analysts are upgrading their estimates. So you may also wish to search this free list of stocks with high insider ownership.
New: AI Stock Screener & Alerts
Our new AI Stock Screener scans the market every day to uncover opportunities.
• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies
Or build your own from over 50 metrics.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About ENXTBR:AGS
ageas
Engages in insurance business.